<code id='F94C90FD1F'></code><style id='F94C90FD1F'></style>
    • <acronym id='F94C90FD1F'></acronym>
      <center id='F94C90FD1F'><center id='F94C90FD1F'><tfoot id='F94C90FD1F'></tfoot></center><abbr id='F94C90FD1F'><dir id='F94C90FD1F'><tfoot id='F94C90FD1F'></tfoot><noframes id='F94C90FD1F'>

    • <optgroup id='F94C90FD1F'><strike id='F94C90FD1F'><sup id='F94C90FD1F'></sup></strike><code id='F94C90FD1F'></code></optgroup>
        1. <b id='F94C90FD1F'><label id='F94C90FD1F'><select id='F94C90FD1F'><dt id='F94C90FD1F'><span id='F94C90FD1F'></span></dt></select></label></b><u id='F94C90FD1F'></u>
          <i id='F94C90FD1F'><strike id='F94C90FD1F'><tt id='F94C90FD1F'><pre id='F94C90FD1F'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:782

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          What don’t we know about an Alzheimer’s drug side effect?
          What don’t we know about an Alzheimer’s drug side effect?

          Illustration:AlexHogan/STAT;Photo:EisaiviaAPSincetheFDA’sapprovaloflecanemab(marketedasLeqembi)andMe

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Why Marc Tessier

          StanfordPresidentMarcTessier-LavigneCindyOrd/GettyImagesStanfordPresidentMarcTessier-Lavigne,whowill